March 1, 2000

Company Press Release

Galileo Laboratories and Procter & Gamble Sign Agreement

Iams & Galileo Form Research and Development Alliance

Santa Clara, CA, & Dayton, OH, March 1, 2000 - Galileo Laboratories, Inc. [www.GalileoLabs.com] and the Iams Company [www.Iams.com], a Procter & Gamble (P&G) subsidiary, announced today that they have entered into a strategic alliance to build a new generation of companion animal nutrition products. Iams, a world's leader and innovator in companion animal nutritionals, and Galileo, a biotechnology company focused on energy metabolism, are joining forces to develop a suite of products focused on meeting the specific needs of companion animals based on lifestyle and age.

"The Iams Company was founded on a basic value - to enhance the well-being of companion animals by providing world-class quality foods," said Dr. Diane Hirakawa, Senior Vice President of Research and Development at Iams. "To achieve this goal, the Iams Company invests considerable capital in the research and development of beneficial companion animal nutrition products. Galileo Laboratories further enables Iams to implement its core mission of employing innovative technologies to build superior companion animal nutritionals," further stated Dr. Hirakawa.

Galileo Laboratories is focused on identifying functional food ingredients, complementary medicines and pharmaceuticals that enhance function during conditions of oxidative and metabolic stress. As oxidative and metabolic stress has been implicated in aging, performance and disease, Galileo is developing an array of products that address these conditions in humans, companion and farm animals.

The two companies will leverage Iams' franchise in the premium companion animal marketplace and Galileo's discovery expertise to develop state-of-the-art products that enhance the health and quality of life of companion animals.

"The partnership with Iams was logical," stated Dr. Guy Miller, CEO, Galileo Laboratories, Inc. “Iams is a global leader in the premium companion animal food marketplace, they possess enhanced marketing and distrubution capabilities and are a respected innovator in developing nutritionals for companion animals. Galileo embraces the same core value as the Iams Company - improving the quality of life through innovation," further stated Dr. Miller.

About Iams

Iams is a leader in the premium segment of the global companion animal food market. This segment, reportedly the fastest-growing sector, represents 10 percent of the estimated $25 billion global market. Financial terms of the agreement between Iams and Galileo were not disclosed.

The Iams Company, which was purchased by P&G in 1999, has enhanced the health and well-being of dogs and cats by providing world-class quality foods for more than 50 years. As a global leader in science-based companion animal nutrition, the company's Eukanuba and Iams brands of dog and cat food are sold in 77 countries.

About Galileo Laboratories

Galileo Laboratories, Inc. is a biotechnology company involved in the discovery and development of compounds associated with the prevention and treatment of diseases caused by oxidative and metabolic stress. The Company develops these compounds as functional food ingredients, complementary medicines, medical foods and pharmaceuticals. In addition to Iams, Galileo alliances include Warner-Lambert, DMV International Nutritionals, Phytera, Inc. and academic institutions such as John Hopkins University, University of Texas, and University of California.

Contact

Peter Leighton, Vice President Marketing
Galileo Laboratories, Inc.
408.654.5830 x 107
Prozac 10 mg tablet